Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
This study has been completed.
Study NCT00292409 Information provided by Otsuka Pharmaceutical Development & Commercialization, Inc.
First Received on September 12, 2005. Last Updated on November 7, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
More general conditions related to this trial
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Physiological Effects of Drugs
Sponsors listed in this trial
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka America Pharmaceutical
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers